Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Vogenx

Tracked across 1 events · 6 articles · First seen Sep 22, 2026 · Last active Sep 22, 2026

Sentiment
5
Attention
1
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
1 5
Business
Vogenx, Inc. (Nasdaq: VOGX), a clinical-stage biopharmaceutical company based in Raleigh, North Carolina, announced the appointment of Ken Toombs to its Board of Directors, effective September 21, 2026. Toombs will serve as an independent director…
Impact: Vogenx is the issuer announcing the appointment of Ken Toombs to its Board of Directors and Audit Committee chair, broadening independent oversight as it scales after its August 2026 IPO. The move is a minor positive governance signal for the clinical-stage biopharmaceutical company.
Sep 22, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Vogenx live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.